Med schools asked to shun drug firm freebies

The Assn. of American Medical Colleges also wants schools to ban or limit drug industry programs such as speakers' bureaus.

By Myrle Croasdale — Posted May 26, 2008

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

Free lunches, pens or trips to resorts from drug companies should not be accepted. Ghostwriting of pharmaceutical research should be prohibited. And participation in industry-backed speakers' bureaus should be discouraged.

A report by the Assn. of American Medical Colleges calls for these and other restrictions to limit drug and medical device companies' interactions at the nation's medical schools and teaching hospitals. The report's recommendations seek to free the educational environment of industry marketing activities, put buffers in place when industry funding is accepted, and distance physicians and trainees from sales representatives' influence, medical leaders said.

AAMC Chief Scientific Officer David Korn, MD, said the recommendations were prompted by concerns that industry funding is increasingly eroding the objectivity and integrity of medical education.

"Those [industry] influences may not be in the best interest of individual patients and may not be in accord with the best evidence available about particular illnesses," he said.

The AAMC's governing board is expected to adopt the report's findings next month, then the organization would urge its member schools to embrace the recommendations. Supporters say the stricter standards should bring sweeping changes to academic medical centers.

"We feel this is a really important starting point," said Robert Restuccia, executive director of the Prescription Project, which helps academic centers and others eliminate conflicts of interest.

The report, released last month, calls for limiting drug reps' access by allowing them to meet with physicians only by appointment and away from patient care areas. Drug samples, if accepted, should be distributed through a central system or pharmacy, the report said.

Cutting out freebies

The AMA permits physicians to accept gifts if they are not of substantial value, $100 or less. But physicians may not accept payment for attending or traveling to conferences. The AMA's Council on Ethical and Judicial Affairs is reviewing policies and may submit changes at the AMA's Annual Meeting in June.

The drug industry's influence on medical education was addressed in 2006 in a Journal of the American Medical Association opinion piece that challenged academic medical centers to take the lead in conflict-of-interest reforms. The AAMC created a task force of pharmaceutical executives, academic leaders, medical students and others to consider reforms, which were detailed in the new report.

"The report came down very strongly on the side of ensuring objectivity and evidence-based decision-making for students and physicians," said Jordan J. Cohen, MD, AAMC past president and co-author of the JAMA article.

However, not everyone supports the recommendations. Task force members Jeff Kindler, CEO of Pfizer, and Sidney Taurel, board chair at Eli Lilly and Co., co-signed a letter stating they oppose discouraging physicians from being in speakers' bureaus. The Pharmaceutical Research and Manufacturers of America disagreed with the AAMC's description of the motives behind industry interactions with academics.

Some schools already have bans and restrictions in place.

R. Van Harrison, PhD, continuing medical education office director at the University of Michigan Medical School in Ann Arbor, said several years ago the school banned free drug samples, discouraged faculty participation in speakers' bureaus and restricted drug reps' campus access.

Faculty members still take part in speakers' bureaus, but trainees' relationships with sales reps have changed. "A couple of reps told me the residents don't recognize them walking down the hall anymore," Dr. Harrison said.

Similar practices were implemented two years ago at Stanford University School of Medicine, said Clarence H. Braddock III, MD, MPH, an associate internal medicine professor at the school and a member of the Stanford Center for Biomedical Ethics.

"Students and residents still attend teaching conferences [but] without the lure of complimentary lunches," he said. "And banning gifts has removed the lingering presence of free advertising on pens and pocket liners."

AAMC's Dr. Korn said it may be easier to change the behavior of students and residents than faculty.

"Physicians and medical scientists are highly trained and believe they behave with extreme rationality and integrity," he said. "They don't believe the free meals -- the apocalyptic pizza -- can possibly influence their decision-making, but there is a rich body of evidence on how effective these activities are."

Back to top


Ending giveaways

Recommendations for academic interactions with drug and medical device firms include:

  • Gifts from industry should not be accepted, on or off campus.
  • Drug samples hould be distributed through a central system, such as a campus pharmacy.
  • Access to physicians by sales reps should be by appointment and outside patient care areas.
  • Speakers' bureaus sponsored by industry should not include faculty.
  • Food should not be provided by industry reps, except at CME events.
  • Travel payments should not be accepted.
  • Ghostwriting, in which authors represent industry research as their own, should not be permitted.

Source: "Report of the AAMC Task Force on Industry Funding of Medical Education to the AAMC Executive Council"

Back to top

External links

"Report of the AAMC Task Force on Industry Funding of Medical Education to the AAMC Executive Council," Assn. of American Medical Colleges, in pdf (link)

Back to top



Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story

Read story


American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story

Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story

Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story

Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story

Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story

Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story

Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn